Well there is your PR freegriff! We are closing in the red, however one positive note from the news is there was no mention of an uplist to NASDAQ in 2014 because that would be one crippling split! I hope they just back off the up list ideas and focus on bringing some near term SH value we have been talking about for quite some time.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links